Tuesday, January 20, 2026 1/20/2026

Novel Lymphocyte Chemoattractant Receptor and Ligand

Award Number: R01AI178113
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/23/2024
PERIOD OF PERFORMANCE END DATE: 12/31/2028

Group Awards By:

View Award Description

Novel Lymphocyte Chemoattractant Receptor and Ligand - PROJECT SUMMARY/ABSTRACT The immune system at mucosal sites has evolved to mediate rapid immunity to invading pathogens, while limiting over-reactive responses that drive chronic inflammation. Mechanisms of lymphocyte trafficking are essential for the function and systemic integration of the immune system, and in particular for targeting immune responses to specific mucosal and epithelial organs and tissues in the body. Despite identification of trafficking receptors for the small intestines, colon, and skin, we have limited knowledge of mechanisms of lymphocyte recruitment to the lung and to most non-intestinal mucosal sites. Defining mechanisms controlling organotypic lymphocyte homing to these tissues which will be critical for developing therapies to control immune pathologies. We have identified a novel lymphocyte chemoattractant receptor and its chemoattractant ligand, selectively expressed in lung, airways, upper GI tract, genitourinary mucosae and mucosa-associated glands including the pancreas and salivary glands. Under Aim 1 we will mechanistically probe the receptor-ligand interactions focusing on the specificity and signaling pathways activated by the novel receptor and its role as a lymphocyte vs myeloid cell chemotactic receptor. Structure-function studies will identify ligand domains for receptor binding and activation. Aim 2 will define the regulation of the receptor in the mouse, and its role in lymphocyte population of and homing to non-lymphoid tissues during homeostasis and in the setting of chronic multi-organ autoimmune inflammation. The roles of the pathway in immune cell development will be probed in mixed bone marrow chimeras in which receptor-deficient vs wild type stem cells compete for reconstitution of immune compartments in lymphoid and non-lymphoid tissues. Aim 3 will elucidate the tissue- and cell subset- specific expression of the receptor and ligand in humans. Regulation of the receptor will be studied in organotypic lymphocyte development and activation, in homeostasis, and in pulmonary immune challenge and infection. We will employ innovative approaches and develop new tools to address the fundamental role of the novel pathway in the immune system, and where possible, translate our findings from mice into humans. Results from these studies will significantly advance our understanding of the systemic organization and integration of the mucosal immune system. The mechanisms identified will provide the basis for new approaches to manipulating immunity and inflammation in the lungs and extraintestinal mucosae.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $671,860 )
2026	2026	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Allergy and Infectious Diseases Research	000	3	1/5/2026	NON-COMPETING CONTINUATION	$671,860
														Subtotal = $671,860

Issue Date FY: 2025 ( Subtotal = $672,536 )
2025	2025	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Allergy and Infectious Diseases Research	000	2	12/13/2024	NON-COMPETING CONTINUATION	$672,536
														Subtotal = $672,536

Issue Date FY: 2024 ( Subtotal = $719,405 )
2024	2024	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Allergy and Infectious Diseases Research	001	1	9/3/2024	NEW	$71,940
2024	2024	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Allergy and Infectious Diseases Research	000	1	2/23/2024	NEW	$647,465
														Subtotal = $719,405

Grand Total All Awards = $2,063,801

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Novel Lymphocyte Chemoattractant Receptor and Ligand

Award Number: R01AI178113

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/23/2024

PERIOD OF PERFORMANCE END DATE: 12/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer